Actively monitor for the clinical characteristics of advanced PV

Despite hydroxyurea (HU) and phlebotomy (PBT) treatment, PV may advance in a subset of patients, resulting in ineffective disease control.1,2 Identifying patients with the clinical characteristics of advanced PV may better inform your treatment decisions.

Image of Hct + characteristics for advanced polycythemia vera
Image of Robyn Scherber, MD, MPH

Given the prevalence of symptoms and the burden they impose on patients, symptom alleviation is a major objective in the evaluation of patients with PV and is frequently included as a clinical trial end point.

—Robyn Scherber, MD, MPH
White Paper—PV-Related Symptoms: A Moving Target for Disease Management

Get expert insights and other support for critical PV topics

Risk of Thrombosis

Get detailed information about how Hct and WBC counts may increase thrombotic risk, including expert insights from Srdan Verstovsek, MD, PhD.


Learn about real patient experiences with PV-related symptoms and review expert opinions and data on this topic.


Browse our robust library of PV resources to support your practice.